Instylla Inc.February 3, 2026Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System
Instylla Inc.August 1, 2022Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
Instylla Inc.March 30, 2021Instylla Announces Enrollment of Initial Patients in the Embrace™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial
